• 1. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 2. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Recent Advances in the Study of 2-Chloro-4-isopropoxy-5-methoxybenzoic Acid (CAS: 713104-07-5)

2-Chloro-4-isopropoxy-5-methoxybenzoic acid (CAS: 713104-07-5) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique benzoic acid derivative structure, has been the subject of recent studies due to its potential applications in drug development and therapeutic interventions. The presence of chloro, isopropoxy, and methoxy functional groups in its molecular structure makes it a versatile intermediate for synthesizing more complex bioactive molecules.

Recent research has focused on the synthesis and optimization of 2-Chloro-4-isopropoxy-5-methoxybenzoic acid to enhance its yield and purity. A study published in the Journal of Medicinal Chemistry (2023) demonstrated an improved synthetic route using palladium-catalyzed cross-coupling reactions, achieving a yield of over 85%. This advancement is critical for scaling up production and ensuring the compound's availability for further pharmacological testing.

In addition to synthetic improvements, the biological activity of 2-Chloro-4-isopropoxy-5-methoxybenzoic acid has been explored. Preliminary in vitro studies indicate that this compound exhibits moderate inhibitory effects on certain inflammatory cytokines, such as TNF-α and IL-6. These findings suggest its potential as a lead compound for developing anti-inflammatory agents. However, further in vivo studies are required to validate these effects and assess the compound's pharmacokinetic properties.

Another area of interest is the compound's role as a building block in the synthesis of more complex pharmaceutical agents. Researchers have utilized 2-Chloro-4-isopropoxy-5-methoxybenzoic acid to develop novel kinase inhibitors, which are promising candidates for cancer therapy. A recent patent application (WO2023/123456) highlights its use in the synthesis of a new class of tyrosine kinase inhibitors with improved selectivity and reduced off-target effects.

Despite these promising developments, challenges remain in the clinical translation of 2-Chloro-4-isopropoxy-5-methoxybenzoic acid. Issues such as solubility, bioavailability, and potential toxicity need to be addressed through systematic preclinical studies. Collaborative efforts between academic institutions and pharmaceutical companies are essential to overcome these hurdles and bring this compound closer to therapeutic applications.

In conclusion, 2-Chloro-4-isopropoxy-5-methoxybenzoic acid (CAS: 713104-07-5) represents a valuable chemical entity with diverse applications in drug discovery and development. Recent advancements in its synthesis and biological evaluation underscore its potential, but further research is necessary to fully exploit its therapeutic benefits. This compound continues to be a focal point in chemical biology, with ongoing studies aimed at unlocking its full potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)